Posters & Publications :: ProMIS Neurosciences, Inc. (PMN)

Second Quarter 2026 Earnings Conference Call Click Here

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

PMN310 | Amyloid-Beta

PMN310 Poster AAIC 2026

PMN440 | A-Syn Vaccine

Vaccination with Conformational Epitopes Derived from Computational Modeling Elicits Active Antibody Response Selective for Toxic Alpha-Synuclein Species

PMN267 | TDP-43

Rational Design of a Vaccine Against TDP-43 Proteinopathies Using a Pathogenic Epitope of Misfolded TDP-43

PMN310 | Amyloid-Beta

Relationship between efficacy and preferential targeting of soluble Aβ aggregates

PMN310 | Amyloid-Beta

Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer’s disease

EpiSelect™ Platform

Protein misfolding-speciﬁc epitope identiﬁcation for passive and active immunotherapy of neurodegenerative diseases

PMN310 | Amyloid-Beta

PRECISE-AD, A Phase 1b, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PMN310 in Patients with Early Alzheimer's Disease

PMN310 | Amyloid-Beta

Leveraging recent advances in biomarkers to optimize early phase drug development in Alzheimer’s Disease

EpiSelect™ Platform

Prediction of Misfolding-Specific Epitopes in SOD1 Using EpiSelect™ (platform formerly called Collective Coordinates)

PMN267 | TDP-43

Rational Generation of Monoclonal Antibodies and Intrabodies Selective for Pathogenic TDP-43

PMN311 | AD Vaccine

Alzheimer's Disease Vaccine Presentation

PMN311 | AD Vaccine

Narration of Alzheimer's Disease Vaccine Presentation